Alzheimer's and dementia drug trial halted before it began
Disease control
Terminated
This study aimed to test a drug called BAC in people with Alzheimer's disease or vascular dementia. The goal was to see if BAC could improve thinking and memory, and to check for side effects. However, the trial was withdrawn before any participants were enrolled, so no results a…
Phase: PHASE2 • Sponsor: Botanicure Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:30 UTC